Philip Stephen Jackson

Person

Harlow, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,613,765
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating cognitive disorders
- Patent number 6,271,230
- Issue date Aug 7, 2001
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-azacyclic derivatives and their use as therapeutic agents
- Patent number 6,172,077
- Issue date Jan 9, 2001
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,114,315
- Issue date Sep 5, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptors antagonists for treating schizophrenic disorders
- Patent number 6,100,256
- Issue date Aug 8, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating amnestic disorders
- Patent number 6,096,729
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating stress disorders
- Patent number 6,087,348
- Issue date Jul 11, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,927
- Issue date Jun 6, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,977,104
- Issue date Nov 2, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,952,315
- Issue date Sep 14, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating sexual dysfunctions
- Patent number 5,929,054
- Issue date Jul 27, 1999
- Merck Sharp
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating movement disorders
- Patent number 5,925,627
- Issue date Jul 20, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antogonists for treating substance use disorders
- Patent number 5,919,781
- Issue date Jul 6, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Philip Stephen Jackson

Person

Patents Grantslast 30 patents

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptor antagonists for treating cognitive disorders

Spiro-azacyclic derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptors antagonists for treating schizophrenic disorders

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating stress disorders

Spiro-piperidine derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating sexual dysfunctions

Use of NK-1 receptor antagonists for treating movement disorders

Use of NK-1 receptor antogonists for treating substance use disorders